Capital World Investors
LAB icon

Capital World Investors’s Standard BioTools LAB Stock Holding History

Capital World Investors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-800,000
Closed -$5.82M – 504
2016
Q4 		$5.82M Hold
800,000
– – ﹤0.01% 466
2016
Q3 		$6.41M Hold
800,000
– – ﹤0.01% 467
2016
Q2 		$7.22M Hold
800,000
– – ﹤0.01% 461
2016
Q1 		$6.46M Hold
800,000
– – ﹤0.01% 463
2015
Q4 		$8.65M Hold
800,000
– – ﹤0.01% 482
2015
Q3 		$6.49M Buy
+800,000
New +$12.6M ﹤0.01% 493

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return